Purpose One in 14 people over 65 years suffer from dementia in the UK. Over 25 per cent are receiving antipsychotics, which cause increases in mortality and cerebrovascular events. The need for a reduction and the use of alternative supportive strategies has been advocated. Risperidone at six‐week intervals is the only antipsychotic licensed for treatment with regular review. The majority of management occurs at primary care level and in care homes. The purpose of this paper is to investigate antipsychotic prescribing practices and patient review in these settings. Design/methodology/approach In total, two surveys comprising questions addressing prescribing practices were developed and distributed electronically to all GP practices and car...
Objective: The aim of this study was to identify factors influencing the prescribing ofpsychotropic ...
BACKGROUND: To produce a practice guideline that includes a set of detailed consensus principles reg...
Background: The gap between high antipsychotic prescription rates for patients with dementia and the...
Purpose One in 14 people over 65 years suffer from dementia in the UK. Over 25 per cent are receivin...
Purpose: One in 14 people over 65 years suffer from dementia in the UK. Over 25 per cent are receivi...
BACKGROUND Up to a quarter of people in the UK with a diagnosis of dementia are prescribed an ant...
Background Anti-psychotics, prescribed to people with dementia, are associated with approximately 1,...
Background: Antipsychotic agents have limited efficacy for Behavioral and Psychological Symptoms of ...
Background: Despite their adverse effects, antipsychotics are frequently used to manage behavioral a...
AbstractBackgroundAntipsychotic medications are commonly used to manage the behavioral and psycholog...
Aisling A Jennings, Naoihse Guerin, Tony Foley Department of General Practice, University College C...
Antipsychotic agents have limited efficacy for Behavioral and Psychological Symptoms of Dementia (BP...
Abstract Residents of nursing homes diagnosed with dementia have long been treated with psychotropic...
Objective: The aim of this study was to identify factors influencing the prescribing ofpsychotropic ...
Background: The gap between high antipsychotic prescription rates for patients with dementia and the...
Objective: The aim of this study was to identify factors influencing the prescribing ofpsychotropic ...
BACKGROUND: To produce a practice guideline that includes a set of detailed consensus principles reg...
Background: The gap between high antipsychotic prescription rates for patients with dementia and the...
Purpose One in 14 people over 65 years suffer from dementia in the UK. Over 25 per cent are receivin...
Purpose: One in 14 people over 65 years suffer from dementia in the UK. Over 25 per cent are receivi...
BACKGROUND Up to a quarter of people in the UK with a diagnosis of dementia are prescribed an ant...
Background Anti-psychotics, prescribed to people with dementia, are associated with approximately 1,...
Background: Antipsychotic agents have limited efficacy for Behavioral and Psychological Symptoms of ...
Background: Despite their adverse effects, antipsychotics are frequently used to manage behavioral a...
AbstractBackgroundAntipsychotic medications are commonly used to manage the behavioral and psycholog...
Aisling A Jennings, Naoihse Guerin, Tony Foley Department of General Practice, University College C...
Antipsychotic agents have limited efficacy for Behavioral and Psychological Symptoms of Dementia (BP...
Abstract Residents of nursing homes diagnosed with dementia have long been treated with psychotropic...
Objective: The aim of this study was to identify factors influencing the prescribing ofpsychotropic ...
Background: The gap between high antipsychotic prescription rates for patients with dementia and the...
Objective: The aim of this study was to identify factors influencing the prescribing ofpsychotropic ...
BACKGROUND: To produce a practice guideline that includes a set of detailed consensus principles reg...
Background: The gap between high antipsychotic prescription rates for patients with dementia and the...